Sales rise 18.12% to Rs 590.62 crore
Net profit of Marksans Pharma rose 29.26% to Rs 88.75 crore in the quarter ended June 2024 as against Rs 68.66 crore during the previous quarter ended June 2023. Sales rose 18.12% to Rs 590.62 crore in the quarter ended June 2024 as against Rs 500.03 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales590.62500.03 18 OPM %21.7520.39 -PBDT140.46110.49 27 PBT120.0296.83 24 NP88.7568.66 29Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
